Valiant Laboratories share news, announcements and annual reports
NSE: VALIANTLABBSE: 543998Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹125.87.
27 Oct: open ₹123.36, high ₹123.36, low ₹123.36
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹670 Cr2,048th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.86
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,312
Valiant Laboratories has 119 announcements on record, routine notices left out; 2 in the 30 days to 28 Oct 2026, the latest on 27 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Valiant Laboratories quarterly results
The board meets on 2 Nov 2026 to consider financial results
Notice filed 27 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Valiant Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Valiant Laboratories financials, year by year
Annual reports3
- Annual report, year to Mar 20263 Sep 2026
- Annual report, year to Mar 20251 Sep 2025
- Annual report, year to Mar 202417 Jul 2024
Valiant Laboratories share news and announcements
Newest first. Page 1 of 3.
Oct 2026
27 Oct · Board meeting
Sep 2026
28 Sep · Meeting
17 Sep · General Updates
3 Sep · Rating
3 Sep · General Updates
Aug 2026
10 Aug · Business
10 Aug · Management
10 Aug · Results
5 Aug · Board meeting
Jun 2026
May 2026
30 May · Legal
25 May · Legal
Exchange has sought clarification from Valiant Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. -2. Segment details not submitted. The response of the Company is awaited.14 May · Business
14 May · Results
11 May · Board meeting
Apr 2026
23 Apr · Management
Feb 2026
11 Feb · Business
11 Feb · Results
6 Feb · Board meeting
Jan 2026
12 Jan · Legal
Exchange has sought clarification from Valiant Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Dec 2025
26 Dec · Legal
Nov 2025
11 Nov · Business
11 Nov · Results
Sep 2025
25 Sep · Management
25 Sep · Meeting
Aug 2025
11 Aug · General Updates
8 Aug · Management
5 Aug · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 4 Sep 2026Credit ratingup 4.99%+5.0 pts vs Nifty 500market median 0.0% · five sessions +23.7% (+24.9 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 11 Aug 2026Resultsup 5.00%+5.3 pts vs Nifty 500market median −0.7% · five sessions +27.6% (+28.4 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 15 May 2026Resultsdown 2.32%−2.0 pts vs Nifty 500market median −0.7% · five sessions −4.3% (−4.3 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 24 Apr 2026Board or managers changedup 0.13%+1.2 pts vs Nifty 500market median 0.0% · five sessions +3.0% (+3.5 pts vs Nifty 500) · volume 3.8× usual · delivery −3.4 pts against usual · The announcement
- 23 Apr 2026Board or managers changedup 11.99%+12.8 pts vs Nifty 500market median 0.0% · five sessions +21.0% (+21.5 pts vs Nifty 500) · volume 1.4× usual · delivery +7.5 pts against usual · The announcement
- 12 Feb 2026Resultsdown 4.92%−4.4 pts vs Nifty 500market median −0.7% · five sessions −10.5% (−9.9 pts vs Nifty 500) · volume 2.3× usual · delivery +18.0 pts against usual · The announcement
- 12 Nov 2025Resultsdown 1.89%−2.5 pts vs Nifty 500market median −0.7% · five sessions −3.1% (−3.7 pts vs Nifty 500) · volume 1.1× usual · delivery +13.0 pts against usual · The announcement
- 26 Sep 2025Board or managers changeddown 3.30%−2.0 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−2.0 pts vs Nifty 500) · volume 0.2× usual · delivery +11.5 pts against usual · The announcement
- 11 Aug 2025Resultsup 4.26%+3.4 pts vs Nifty 500market median −0.7% · five sessions +2.1% (−0.1 pts vs Nifty 500) · volume 0.7× usual · delivery +3.8 pts against usual · The announcement
- 26 Jun 2025Credit ratingdown 2.17%−3.1 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−2.3 pts vs Nifty 500) · volume 0.6× usual · The announcement
11 earlier announcements
- 2 Jun 2025Resultsup 4.61%+4.5 pts vs Nifty 500market median −0.7% · five sessions +3.9% (+2.3 pts vs Nifty 500) · volume 2.7× usual · The announcement
- 19 Feb 2025Credit ratingup 0.02%−0.6 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−2.1 pts vs Nifty 500) · volume 0.3× usual · delivery −9.0 pts against usual · The announcement
- 10 Feb 2025Resultsdown 3.18%−1.9 pts vs Nifty 500market median −0.7% · five sessions −10.7% (−6.0 pts vs Nifty 500) · volume 0.2× usual · delivery −3.1 pts against usual · The announcement
- 13 Nov 2024Resultsdown 2.37%−0.5 pts vs Nifty 500market median −0.7% · five sessions −0.4% (+1.9 pts vs Nifty 500) · volume 1.3× usual · delivery +6.9 pts against usual · The announcement
- 13 Nov 2024Board or managers changeddown 2.37%−0.5 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+1.9 pts vs Nifty 500) · volume 1.3× usual · delivery +6.9 pts against usual · The announcement
- 23 Aug 2024Credit ratingdown 2.22%−2.1 pts vs Nifty 500market median 0.0% · five sessions +1.3% (+0.5 pts vs Nifty 500) · volume 0.7× usual · delivery −0.1 pts against usual · The announcement
- 13 Aug 2024Resultsdown 4.54%−3.6 pts vs Nifty 500market median −0.7% · five sessions −12.9% (−14.4 pts vs Nifty 500) · volume 0.7× usual · delivery +16.7 pts against usual · The announcement
- 12 Apr 2024Credit ratingdown 1.56%−0.8 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−3.1 pts vs Nifty 500) · volume 0.5× usual · delivery −26.7 pts against usual · The announcement
- 1 Apr 2024Board or managers changedup 5.17%+4.0 pts vs Nifty 500market median 0.0% · five sessions +14.3% (+12.1 pts vs Nifty 500) · volume 0.6× usual · delivery −19.2 pts against usual · The announcement
- 22 Feb 2024Credit ratingdown 0.11%−0.9 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−0.9 pts vs Nifty 500) · volume 0.5× usual · delivery +3.7 pts against usual · The announcement
- 28 Nov 2023Credit ratingup 0.35%−0.2 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−7.2 pts vs Nifty 500) · volume 0.5× usual · delivery +1.0 pts against usual · The announcement
Valiant Laboratories results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.